Leukemia: CLL - Chronic Lymphocytic Leukemia: A combination treatment of fludarabine, cyclophosphamide, and rituximab shows significant better results in time to disease progression and survival in Hodgkin and non-CLL - Chronic Lymphocytic Leukemia. Article updated August 16, 2011